期刊文献+

碱性蓝B探针吸收光谱法测定美司那 被引量:1

Determination of Mesna by Absorption Spectrometry with Basic Blue B as Probe
下载PDF
导出
摘要 在pH 7.93的Britton-Robinson(BR)溶液中,美司那与碱性蓝B反应生成蓝色离子缔合物,光谱曲线上呈现1个强的正吸收峰和1个较强的负吸收峰,正吸收峰位为580 nm,表观摩尔吸光系数(κ)为7.04×10^4 L/(mol·cm),负吸收峰位为430 nm,表观摩尔吸光系数(κ)为1.03×10^4 L/(mol·cm),在此二个波长处,美司那的质量浓度为0~2.7 mg/L范围内服从朗伯-比尔定律,据此建立了测定美司那的正吸收光谱法和负吸收光谱法。该法用于市售美司那药物中美司那的测定,加标回收率为97.9%~98.9%,相对标准偏差(RSD)(n=5)为2.5%~2.8%。 In Britton-Robinson(BR)solution(pH=7.93),mesna reacted with basic blue B to form an ionic association complex with both positive and negative absorption peaks on the spectrum.The positive absorption peak was located at 580 nm with an apparent molar absorptivity(κ)of 7.04×10^4 L/(mol·cm),while the negative absorption peak was located at 430 nm with an apparent molar absorptivity(κ)of 1.03×10^4 L/(mol·cm).At both wavelengths,the mass concentration of mesna obeyed the Lambert-Beer’s law in the range from 0 to 2.7 mg/L.Thus,both positive and negative absorption spectroscopy for the determination of mesna were established.The method has been applied to determine the content of mesna in commercially available mesna-containing drugs with an add standard recoveries of 97.9%~98.9%and relative standard deviation(RSD)(n=5)of 2.5%~2.8%.
作者 刘晓红 江虹 李晓彤 Liu Xiaohong;Jiang Hong;Li Xiaotong(College of Chemistry and Chemical Engineering,Yangtze Normal University,Chongqing 408100,China)
出处 《化学世界》 CAS CSCD 2020年第8期543-547,共5页 Chemical World
基金 重庆市教委科技基金(No.KJ1401226) 长江师范学院科技基金(No.2018CXX123)资助项目。
关键词 美司那 碱性蓝B 正吸收 负吸收 吸收光谱法 mesna basic blue B positive absorption negative absorption absorption spectrometry
  • 相关文献

参考文献2

二级参考文献24

  • 1赵平,欧莉,王建塔.美司钠合成工艺的改进[J].贵阳医学院学报,2006,31(6):589-589. 被引量:3
  • 2Weiss KM,Jariwala S,Wachs J. Fixed drug eruption caused by mesna[J].Annals of Allergy,Asthma & Immunology,2011,(04):377-8.
  • 3Dorris K,Fouladi M,Davies SM. Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor[J].Journal of Pediatric Hematology Oncology,2011,(06):250-2.
  • 4Cutler MJ,Urquhart BL,Velenosi TJ. In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna[J].Journal of Clinical Pharmacology,2011.153-6.
  • 5国家食品药品监督管理局.WS1-(X-096)-2003Z.国家药品标准(试行),国家药品标准(试行)</a>[S].
  • 6Cox P J.Cyclophosphamide cystitis:identification of acrolein as the causative agent[J].Biochemical pharmacology,1979,28(13):2045-2049.
  • 7Cox P J.Cyclophosphamide cystitis and bladder cancer.A hypothesis[J].European Journal of Cancer,1979,15(8):1071-1072.
  • 8Brock N,Pohl J,Stekar J.Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds[J].Journal of cancer research and clinical oncology,1981,100(3):311-320.
  • 9Thackery E.The Gale encyclopedia of cancer[M].Thomson Delmar Learning,2002.
  • 10中国药典委员会.中国药典[J].北京:中国医药科技出版社,2010.

共引文献8

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部